Clinical Trials Browser

Interventional × Triple Negative Breast Neoplasms × sitravatinib × Clear all

NCT04123704 2024-08-26

Sitravatinib in Metastatic Breast Cancer

Phase 2 Terminated

3 enrolled 13 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04734262 2023-11-18

SPARK

Phase 2 Unknown

Breast Neoplasms, Triple Negative Breast Neoplasms